Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Retatrutide is an investigational peptide being studied for its effects on metabolism, appetite regulation, and body weight. It works by activating three key hormone receptors involved in energy balance: GLP-1, GIP, and glucagon.
Recent Phase 3 clinical trial results have shown significant potential, with participants experiencing up to 28.7% average body weight reduction over 68 weeks at higher doses. Because of these results, Retatrutide has become a major focus in ongoing metabolic and obesity research.
Retatrutide is an investigational peptide being studied for its effects on metabolism, appetite regulation, and body weight. It works by activating three key hormone receptors involved in energy balance: GLP-1, GIP, and glucagon.
Recent Phase 3 clinical trial results have shown significant potential, with participants experiencing up to 28.7% average body weight reduction over 68 weeks at higher doses. Because of these results, Retatrutide has become a major focus in ongoing metabolic and obesity research.